Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 4NETWORK 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2Meningeal Carcinomatosis 1Leiomyosarcoma 1Extrapancreatic Neuroendocrine Tumor 1Adenoma, Islet Cell 1

Interventions

Thalidomide 1Temozolomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Adenoma, Islet Cell × Temozolomide × Clear all
NCT03204019 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown
60 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡